MedTrace Logo

Aminopterin Dose Finding Treatment for Methotrexate-Naïve Rheumatoid Arthritis

NCT01724931 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 175

Last updated 2015-05-20

No results posted yet for this study

Summary

The purpose of this study is to determine whether aminopterin is effective in the treatment of rheumatoid arthritis (RA).

Conditions

Interventions

DRUG

LD-aminopterin

DRUG

placebo

Sponsors & Collaborators

  • Syntrix Biosystems, Inc.

    lead INDUSTRY

Principal Investigators

  • Stuart Kahn, MD, MS · Syntrix Biosystems, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2014-09-30
Completion
2015-02-28

Countries

  • Ukraine

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01724931 on ClinicalTrials.gov